CME Group, Chubb, Berkshire Hathaway And More On CNBC's 'Final Trades'

Zinger Key Points
  • CME Group has a free cash flow of $3.5 billion, says Kevin Simpson.
  • Joshua Brown names Berkshire Hathaway as his final trade.

On CNBC's “Halftime Report Final Trades,” Kevin Simpson of Capital Wealth Planning said CME Group Inc. CME yields a 4.5% dividend and trades at a forward PE of 21, which is pretty low. The company has a free cash flow of $3.5 billion.

On Aug. 2, CME Group reported its July market statistics set a new July average daily volume (ADV) record of 24.8 million contracts, up 24% from the year-ago month.

Bill Baruch of Blue Line Capital said Chubb Limited CB is the best in breed. Warren Buffett is a big fan of that stock.

On July 23, Chubb posted better-than-expected second-quarter earnings. The company reported quarterly earnings of $5.38 per share which beat the analyst consensus estimate of $5.15. The company reported quarterly sales of $11.780 billion which beat the analyst consensus estimate of $11.642 billion.

Don't forget to check out our premarket coverage here

Joshua Brown of Ritholtz Wealth Management said Berkshire Hathaway Inc. BRK continues to move higher.

On July 22, TD Cowen analyst Andrew Kilgerman initiated coverage on Berkshire Hathaway with a Hold rating and announced a price target of $465.

Liz Young of SoFi named iShares U.S. Medical Devices ETF IHI as her final trade.

Price Action:

  • CME Group shares fell 0.5% to close at $214.10 during Thursday's session.
  • Chubb shares gained 1.2% to settle at $281.98 during Thursday's session.
  • Berkshire Hathaway shares gained 0.8% to settle at $468.37 on Thursday.
  • iShares U.S. Medical Devices ETF rose 0.5% during Thursday's session.

Check This Out:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Long IdeasNewsTop StoriesMarketsMediaTrading IdeasBill BaruchCNBCHalftime Report Final TradesJoshua BrownKevin SimpsonLiz Young
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!